The systemic inflammatory response has been recognized as the seventh major hallmark of cancers.[4,5] C-reactive protein (CRP) is a serum-based marker of the systemic inflammatory response and is a predictor of low survival rates for patients with cervical cancer and pancreatic cancer. Here, CRP is linked to familial pancreatic carcinoma.